Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Interest Coverage Ratio (2016 - 2017)

Capricor Therapeutics has reported Interest Coverage Ratio over the past 7 years, most recently at 40.85 for Q4 2017.

  • Quarterly results put Interest Coverage Ratio at 40.85 for Q4 2017, down 44.29% from a year ago — trailing twelve months through Sep 2018 was 190.54 (down 542.59% YoY), and the annual figure for FY2025 was 35.51, changed.
  • Interest Coverage Ratio for Q4 2017 was 40.85 at Capricor Therapeutics, down from 24.5 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for CAPR hit a ceiling of 24.5 in Q3 2017 and a floor of 385.96 in Q1 2013.
  • Median Interest Coverage Ratio over the past 5 years was 48.22 (2014), compared with a mean of 74.87.
  • Biggest five-year swings in Interest Coverage Ratio: surged 89.59% in 2014 and later tumbled 87.0% in 2015.
  • Capricor Therapeutics' Interest Coverage Ratio stood at 63.98 in 2013, then soared by 61.37% to 24.71 in 2014, then plummeted by 109.04% to 51.66 in 2015, then soared by 45.2% to 28.31 in 2016, then tumbled by 44.29% to 40.85 in 2017.
  • The last three reported values for Interest Coverage Ratio were 40.85 (Q4 2017), 24.5 (Q3 2017), and 32.02 (Q2 2017) per Business Quant data.